Myhep All Tablet
Myhep All Tablet
Sofosbuvir (400mg) + Velpatasvir (100mg)
Hepcvel Tablet
Cipla Ltd
Velpatasvir 100mg
Pack Size
bottle of 28 tablets
Price
Save ₹875
that's 6% off!
About This Medicine
Product description & overview
Myhep All Tablet is a pharmaceutical formulation comprising Sofosbuvir 400mg and Velpatasvir 100mg, a fixed-dose combination antiviral medication. This product is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults, including those with compensated cirrhosis. The dual antiviral action of Sofosbuvir and Velpatasvir helps inhibit HCV replication, potentially leading to sustained virologic responses and improvement in liver function. The recommended dosage is one tablet once daily with or without food. Consult a healthcare professional for dosing instructions and to monitor for potential adverse effects, drug interactions, and treatment efficacy. Myhep All Tablet should be used as part of a comprehensive treatment plan for HCV, including lifestyle modifications and regular follow-ups.
Active composition
Sofosbuvir 400 mg
+1 more active ingredient
About Sofosbuvir
Sofosbuvir is an antiviral medication used to treat chronic hepatitis C virus (HCV) infection. It lowers HCV levels in the blood and is often used in combination with other antiviral agents. Its clinical relevance lies in effectively managing HCV infections. In summary, Sofosbuvir is vital for treating hepatitis C.
How It Works
Sofosbuvir inhibits the HCV NS5B polymerase, preventing viral replication.
All Active Ingredients
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Information regarding the use of Myhep All Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Myhep All Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Driving
Myhep All Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Myhep All Tablet may be needed. Please consult your doctor. Limited information is available on the use of Myhep All Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Exercise Caution
Breastfeeding
Myhep All Tablet may cause side effects which could affect your ability to drive. Myhep All Tablet, when taken together with other medicines for the treatment of hepatitis c infection, may produce dizziness, blurred vision and this may affect your ability to drive.
Consult Doctor
Kidney
Myhep All Tablet is safe to use in patients with liver disease. No dose adjustment of Myhep All Tablet is recommended. However, inform your doctor if you have any kidney disease as regular monitoring of liver function tests may be advised in some patients while taking this medicine.
Regular Checkup
Customer Reviews
0 reviews for Myhep All Tablet
Products matching your search
Eltropag 50mg Tablet
Eltropag 50mg Tablet
Eltromag 50 Tablet
Eltromag 50 Tablet
Hepcvel Tablet
Hepcvel Tablet
Mydekla 60 Tablet
Mydekla 60 Tablet
Eltromag 25 Tablet
Eltromag 25 Tablet
MYDACLA 60MG TABLET
MYDACLA 60MG TABLET
Hepcinat Tablet
Hepcinat Tablet
Eltropag 25mg Tablet